Summary.-Rabbits were injected with VX2 cancer cells into the left thigh or tibia, and given indomethacin 1-16 mg/kg daily starting on the day before tumour implantation or 7, 14 or 21 days after implantation. Indomethacin at 2 mg/kg and above from before tumour implantation reduced osteoclast proliferation and the amount of prostaglandin-like material extracted from homogenates of excised tumours, but the inhibition of bone destruction in vivo was significant only with indomethacin at 4 mg/kg and above. Indomethacin at 8 mg/kg reduced osteoclast proliferation and bone destruction, but the effect was statistically significant only when given within 7 days of inoculation with the tumour.
THERE IS much evidence that the development of skeletal metastases is associated with the ability of cancer cells to form prostaglandins (Powles et al., 1973; Bennett et at., 1975 Bennett et at., , 1977 Voelkel et al., 1975; Galasko & Bennett, 1976) . Furthermore, prostaglandin-synthesis inhibitors of the aspirin type inhibit the following: hypercalcaemia and osteolysis in rats with the Walker tumour (Powles et al., 1973) ; hypercalcaemia in patients with various non-haematological tumours (Seyberth et al., 1975) ; osteolysis and osteoclast proliferation in rabbits bearing the VX2 carcinoma (Galasko & Bennett, 1976) . However, in these experiments treatment with prostaglandin-synthesis inhibitors was started at the time of tumour inoculation, unlike the timing of therapy that would be feasible in man. This paper examines the importance of administering indomethacin at appropriate times and dosages to obtain maximum effects on tumour prostaglandin formation, osteoclast proliferation and osteolysis.
MATERIALS AND AIETHODS
The VX2 carcinoma wias chosen since previous studies (e.g. Galasko & Bennett, 1976) showr it to be a good model of skeletal destruction by tumour. Tumour-cell suspensions, prepared as described previously (Galasko, 1976) were administered to New Zealand white rabbits of either sex weighing about 3 kg. The rabbits were housed in individual cages and killed 28 days or, sometimes, up to 35 days later.
There were 4 separate experiments. In the first, 1 ml tumour cell suspension (2-5 x 106 cells/ml) was injected into the left thigh muscle of each rabbit. Fifty-eight rabbits were given indomethacin (8 mg/kg daily) in their drinking water, starting on the day of tumour implantation or 1, 7, 14 or 21 days after implantation (9, 14, 12, 12 and 11 rabbits respectively). The indomethacin was dissolved in ethanol (5 mg/ml) which was added to the drinking water of the test animals. During the first 3 weeks each animal drank its own supply of water containing the daily dose, and was given more water alone if required. However, during the 4th week, when the animals were becoming ill from disseminated carcinoma, the fluid consumption occasionally diminished. Fifty-eight animals served as controls, each being paired with an experimental animal and receiving tumour from the same donor. Each pair of animals was killed simultaneously, and weighed amounts of tumour were examined for prostaglandin-like material (Bennett et al., 1973) . Tissue was homogenized in either 50%O ethanol acidified to pH 3 with formic acid to indicate "basal" amounts, or in Krebs solution wihich allowNNs prostaglandin synthesis from endogenous precursors released during tissue disruption (yielding "total" prostaglandins, since it includes newly synthesized and "basal" amounts). The prostaglandin-like material, characterized in other studies as mainly PGE2 (Voelkel et al., 1975; Galasko & Bennett, 1976) w%Aas extracted and assayed against PGE2 using a rat gastric fundus strip preparation, as described by Unger et al. (1971) .
In the 2nd experiment, 72 rabbits wiere subdivided into 6 equal groups. Each rabbit was injected with 1 ml tumour-cell suspension into the left thigh muscle. One group served as controls, and the remainder received 1, 2, 4, 8 or 16 mg indomethacin/kg daily in their drinking w%Nater, starting one day before the injection of cancer cells. Six animals (one from each group) received tumour from the same donor, and were killed simultaneously. Tumour prostaglandins w ere examined as in the first experiment.
In the 3rd experiment, 104 rabbits wvere each injected with 1 ml tumour-cell suspension into the left tibia through a drill hole (Galasko & Bennett, 1976) . Thirty animals served as controls, and the remainder were given indomethacin in their drinking water as followis: 1, 2, 4, 8 or 16 mg/kg daily starting on the day prior to tumour implantation; or 8 mg/kg daily starting the day prior to, or 1, 7, 14 or 21 days after, tumour implantation.
Animals in each group were killed simultaneously, and the tibiae decalcified in 500 nitric acid after removal. Longitudinal sections were cut through the middle of the tibia and its tumour. After staining with haematoxylin and eosin, the sections were examined using a light microscope ( x 275) with a crosshatched graticule. An osteoclast was counted if it lay under one of the cross-hatches, but not if it lay between 2 cross-hatches (Galasko & Bennett, 1976) . Six hundred randomly selected sites along bone edges were examined in each of 2 sections from each tibia, and the number of osteoclasts per 600 sites was calculated.
The amount of bone destruction (number of squares per longitudinal section) was measured in 2 sections from each tibia, using a cross-hatched graticule w%ith a grid of 10 x 10 squares (magnification x 20).
In the 4th experiment, 1mm cubes of VX2 tumour growing in the thigh of indomethacintreated animals wAere incubated in modified Bigger's medium (Harris et al., 1973) at 37°C in an atmosphere of 5% CO2 in air for 48 h, and then incubated for a further 48 h with mouse calvaria. Osteolysis was estimated by measuring calcium release into the culture fluid, using absorption spectrometry.
RESULTS
The results, shown in Tables I to IV , are means + s.e. analysed using Student's t test for paired or unpaired data as appropriate. (Table II) . (The lack of a significant effect of I mg/kg on "total" or "basal" prostaglandin might be due to the dilution of indomethacin within the tumour during homogenization in Krebs solution, tihus allowing prostaglandiii synthesis.) Indomethacin in doses of at, least 2 mg/ kg started one day before inoculation with tumour significantly reduced the amounts of prostaglandin and osteoclast proliferation; the inhibition of bone destruction was statistically significant only with 4 mg/kg and above, probably because of the small numbers at the lower doses (Table III) . The effects of different doses of indomethacin on amounts of prostaglandin, osteoclast proliferation and bone destruction tended to followr the same curve ( Fig.) .
Indomethacin at 8 lmg/kg significantly reduced osteoclast proliferation and bone destruction only when started within 7 days of tumour inoculation (Table IV) . Because the number of rabbits in whom the indomethacin was started 14 days or 21 days after tumour transplantation are small they have been combined for statistical analysis. These results were not signiificantly different from controls, and the amount of bone destruction was greater than in rabbits given indomethacin from Day 7 onwards (Table IV) .
All tumours removed from animals treated with indomethacin produced significantly less osteolysis than controls in culture with mouse calvarium (Table IV) . This occurred irrespective of the timing of drug administration, even though indomethacin was not added to the culture medium, and despite prior tumour culture without indomethacin for 48 h. Thus some cyclo-oxygenase may have been inhibited by residual indomethacin, or some of the enzyme may have been irreversibly inhibited (Lands et al., 1973) .
D)ISCUSSION
Our experiments confirm and extend previous results obtained by ourselves and others. Administration of indomethacin to rabbits can reduce the formation of prostaglandin-like material by VX2 tumours, reduce osteoclast proliferation, and inhibit bone destruction (Voelkel et al., 1975 : Galasko & Bennett, 1976 . The timing of drug administration is important, but has not previously been examined with regard to the growth of tumours in bone. Galasko (1976) 
